We are live on
!
Find out more
CM
Castleark Management Portfolio holdings
AUM
$3.02B
1-Year Est. Return
53.92%
This Fund
S&P 500
This Quarter
Est. Return
-4.29%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$2.89B
AUM Growth
+$18.3M
(+0.64%)
Cap. Flow
+$236M
Cap. Flow
% of AUM
8.19%
Top 10 Holdings %
Top 10 Hldgs %
40.26%
Holding
355
New
72
Increased
84
Reduced
52
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CastleArk Large Growth ETF
CARK
|
+$326M |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$55.7M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$33.9M |
| 4 |
Eli Lilly
LLY
|
+$30.7M |
| 5 |
Accenture
ACN
|
+$21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$56.4M |
| 2 |
Broadcom
AVGO
|
+$44.2M |
| 3 |
Apollo Global Management
APO
|
+$37.5M |
| 4 |
Microsoft
MSFT
|
+$26.2M |
| 5 |
Trade Desk
TTD
|
+$23.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.31% |
| 2 | Healthcare | 10.19% |
| 3 | Financials | 9.99% |
| 4 | Consumer Discretionary | 8.59% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EUAD
126
Select STOXX Europe Aerospace & Defense ETF
EUAD
$1.2B
| $4.93M | 0.17% |
+147,000
| New | +$4.33M |
|
127
The Ensign Group
ENSG
$10.4B
| $4.87M | 0.17% |
37,600
+850
| +2% | +$113K |
|
128
HSBC
HSBC
$367B
| $4.84M | 0.17% |
+84,200
| New | +$4.6M |
|
129
Krystal Biotech
KRYS
$10.8B
| $4.71M | 0.16% |
+26,120
| New | +$4.39M |
|
130
iShares MSCI Emerging Markets ETF
EEM
$28.6B
| $4.71M | 0.16% |
107,715
| – | – |
|
131
Citigroup
C
$222B
| $4.69M | 0.16% |
66,064
+62,220
| +1,619% | +$4.74M |
|
132
Shake Shack
SHAK
$2.54B
| $4.64M | 0.16% |
+52,630
| New | +$5.71M |
|
133
Associated Banc-Corp
ASB
$5.8B
| $4.47M | 0.16% |
198,520
+38,840
| +24% | +$932K |
|
134
Phreesia
PHR
$656M
| $4.31M | 0.15% |
+168,720
| New | +$4.59M |
|
135
GeneDx Holdings
WGS
$2.05B
| $4.23M | 0.15% |
47,810
-13,900
| -23% | -$1.21M |
|
136
Brink's
BCO
$4.84B
| $4.21M | 0.15% |
48,920
-28,010
| -36% | -$2.54M |
|
137
Mattel
MAT
$4.42B
| $4.21M | 0.15% |
+216,430
| New | +$4.29M |
|
138
Williams Companies
WMB
$86.7B
| $4.19M | 0.15% |
70,110
+44,540
| +174% | +$2.55M |
|
|
CPRX
139
DELISTED
Catalyst Pharmaceutical
CPRX
| $4.17M | 0.14% |
+171,890
| New | +$3.87M |
|
140
Insmed
INSM
$22B
| $4.11M | 0.14% |
53,860
+1,080
| +2% | +$82.6K |
|
141
Penumbra
PEN
$12.6B
| $4.08M | 0.14% |
+15,245
| New | +$4.12M |
|
142
Fabrinet
FN
$15.7B
| $4.07M | 0.14% |
+20,590
| New | +$4.49M |
|
143
Royal Caribbean
RCL
$86.1B
| $4.05M | 0.14% |
+19,720
| New | +$4.65M |
|
144
Cheniere Energy
LNG
$54.1B
| $4M | 0.14% |
17,296
+330
| +2% | +$74.3K |
|
145
Littelfuse
LFUS
$11.2B
| $3.95M | 0.14% |
+20,080
| New | +$4.6M |
|
146
Tarsus Pharmaceuticals
TARS
$2.6B
| $3.85M | 0.13% |
+74,920
| New | +$3.7M |
|
147
Kratos Defense & Security Solutions
KTOS
$8.66B
| $3.84M | 0.13% |
+129,170
| New | +$3.92M |
|
148
MPLX
MPLX
$58.5B
| $3.75M | 0.13% |
70,132
-59,510
| -46% | -$3.12M |
|
149
BridgeBio Pharma
BBIO
$16.1B
| $3.7M | 0.13% |
+106,980
| New | +$3.61M |
|
150
Paymentus
PAY
$4.39B
| $3.7M | 0.13% |
141,650
+42,150
| +42% | +$1.25M |
|
Similar funds
MCM
JIC
CFM
SM
TAM
KIA
BGDI
Castleark Management's Q1 2025 Portfolio in Review
As of Q1 2025, Castleark Management held 355 positions worth $2.89B, up 0.64% from $2.87B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Castleark Management deployed $236M of net new capital in Q1 2025, opening 72 new positions and adding to 84 existing holdings. Its largest new stake was CastleArk Large Growth ETF: 8,394,730 shares worth $295M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $56.4M trimmed.
- Castleark Management's largest Q1 2025 buy was CastleArk Large Growth ETF: 8,394,730 shares worth $295M.
- Castleark Management added most to iShares US Treasury Bond ETF in Q1 2025, an estimated $55.7M increase.
- Castleark Management's biggest Q1 2025 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $56.4M.
- Castleark Management fully exited Apollo Global Management in Q1 2025, selling an estimated $37.5M.
- Castleark Management's ten largest holdings make up 40% of its $2.89B portfolio in Q1 2025.
- Castleark Management opened 72 new positions and closed 75 in Q1 2025.
- Castleark Management's portfolio value rose 0.64% quarter-over-quarter to $2.89B.
Based on Castleark Management's 13F filing for Q1 2025, filed 15 May 2025.